Millennium Management’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,061
| Closed | -$55.9K | – | 6605 |
|
|
2024
Q2 | $55.9K | Sell |
10,061
-116,098
| -92% | -$412K | ﹤0.01% | 5400 |
|
|
2024
Q1 | $492K | Buy |
126,159
+93,698
| +289% | +$357K | ﹤0.01% | 4826 |
|
|
2023
Q4 | $140K | Sell |
32,461
-57,350
| -64% | -$194K | ﹤0.01% | 5262 |
|
|
2023
Q3 | $278K | Buy |
89,811
+50,429
| +128% | +$167K | ﹤0.01% | 4972 |
|
|
2023
Q2 | $115K | Buy |
39,382
+10,620
| +37% | +$24.4K | ﹤0.01% | 5295 |
|
|
2023
Q1 | $60K | Buy |
28,762
+16,799
| +140% | +$39K | ﹤0.01% | 5568 |
|
|
2022
Q4 | $32K | Buy |
+11,963
| New | +$50.9K | ﹤0.01% | 5917 |
|
|
2022
Q1 | – | Sell |
-12,716
| Closed | -$65K | – | 7661 |
|
|
2021
Q4 | $65K | Buy |
+12,716
| New | +$62.2K | ﹤0.01% | 6407 |
|
|
2019
Q3 | – | Sell |
-1,044
| Closed | -$14K | – | 4637 |
|
|
2019
Q2 | $14K | Buy |
+1,044
| New | +$14.7K | ﹤0.01% | 3983 |
|
|
2018
Q4 | – | Sell |
-1,170
| Closed | -$17K | – | 4272 |
|
|
2018
Q3 | $17K | Buy |
+1,170
| New | +$17.8K | ﹤0.01% | 3833 |
|
|
2018
Q1 | – | Sell |
-1,101
| Closed | -$22K | – | 4175 |
|
|
2017
Q4 | $22K | Sell |
1,101
-353
| -24% | -$6.89K | ﹤0.01% | 3742 |
|
|
2017
Q3 | $29K | Sell |
1,454
-26
| -2% | -$556 | ﹤0.01% | 3433 |
|
|
2017
Q2 | $31K | Buy |
+1,480
| New | +$31.7K | ﹤0.01% | 3378 |
|
|
2017
Q1 | – | Sell |
-2,297
| Closed | -$37K | – | 3921 |
|
|
2016
Q4 | $37K | Sell |
2,297
-4,776
| -68% | -$87.4K | ﹤0.01% | 3265 |
|
|
2016
Q3 | $158K | Sell |
7,073
-4,534
| -39% | -$104K | ﹤0.01% | 3041 |
|
|
2016
Q2 | $214K | Buy |
+11,607
| New | +$309K | ﹤0.01% | 2877 |
|
|
2016
Q1 | – | Sell |
-11,784
| Closed | -$428K | – | 3746 |
|
|
2015
Q4 | $428K | Buy |
11,784
+649
| +6% | +$28.2K | ﹤0.01% | 2724 |
|
|
2015
Q3 | $369K | Sell |
11,135
-8,471
| -43% | -$477K | ﹤0.01% | 2810 |
|
|
2015
Q2 | $1.36M | Sell |
19,606
-7,469
| -28% | -$515K | ﹤0.01% | 2123 |
|
|
2015
Q1 | $2.04M | Buy |
27,075
+3,502
| +15% | +$276K | ﹤0.01% | 1931 |
|
|
2014
Q4 | $1.96M | Buy |
23,573
+13,883
| +143% | +$1.13M | ﹤0.01% | 1989 |
|
|
2014
Q3 | $788K | Sell |
9,690
-48
| -0.5% | -$4.1K | ﹤0.01% | 2461 |
|
|
2014
Q2 | $874K | Sell |
9,738
-5,507
| -36% | -$489K | ﹤0.01% | 2275 |
|
|
2014
Q1 | $1.8M | Buy |
+15,245
| New | +$1.48M | 0.01% | 1856 |
|
Millennium Management's ALIM Position: Q3 2024 in Review
Millennium Management sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 10,061 shares — an estimated $55.9K sold.
Millennium Management first reported a position in ALIM in Q1 2014 and held it in 24 quarters. The position peaked at $2.04M in Q1 2015. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- Millennium Management reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- Millennium Management sold 10,061 Alimera Sciences shares in Q3 2024, an estimated $55.9K.
- Millennium Management first reported a position in Alimera Sciences in Q1 2014 and held it in 24 quarters.
- Millennium Management's Alimera Sciences position peaked at $2.04M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.